Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| PCSA | Processa Pharmaceuticals | $5.80 | $2.80 | 93.14% | 20.3M | $170M | $2.74$27.00 |
| MGRT | Mega Fortune | $8.11 | $2.76 | 51.59% | 483.4K | $74M | $1.50$9.68 |
| ISPO | Inspirato | $4.17 | $1.33 | 46.83% | 8.1M | $36M | $2.19$7.17 |
| GVH | Globavend | $3.84 | $0.89 | 30.27% | 239.8K | $3.7M | $2.95$364.00 |
| TGL | Treasure Global | $7.80 | $1.65 | 26.83% | 2.2M | $5.2M | $4.51$780.00 |
| DDL | Dingdong (Cayman) | $2.83 | $0.55 | 24.12% | 211.2K | $412M | $1.65$4.23 |
| DBVT | Dbv Technologies | $21.95 | $3.97 | 22.08% | 170.1K | $722M | $2.74$26.20 |
| UDMY | Udemy | $6.55 | $1.18 | 21.88% | 19.5M | $786M | $4.86$10.61 |
| RXRX | Recursion Pharmaceuticals | $4.89 | $0.69 | 16.31% | 40.2M | $2.2B | $3.79$12.36 |
| NRXP | NRx Pharmaceuticals | $2.40 | $0.30 | 14.29% | 18K | $59M | $1.40$6.01 |
Related Articles
Featured Article
Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock?
Prosper Junior Bakiny|Nov 24, 2025
Getting in on the ground floor would be great, but only if there's massive upside ahead for the company.
Is Recursion Pharmaceuticals a Meme Stock?
Prosper Junior Bakiny|Nov 19, 2025
The answer seems straightforward enough.
3 Things Investors Need to Know About Recursion Pharmaceuticals
Prosper Junior Bakiny|Nov 4, 2025
Can this under-the-radar stock be a great way to cash in on AI?
Advertisement
Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock?
David Jagielski, CPA|Oct 31, 2025
Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.
Up 25% in 1 Month, Is This Stock a Buy?
Prosper Junior Bakiny|Oct 21, 2025
It might look like this beaten-down AI-focused company is finally bouncing back, but don't be too quick to pull the trigger.
Where Will Recursion Pharmaceuticals Be in 5 Years?
Prosper Junior Bakiny|Sep 28, 2025
Could investing in this stock be an underrated way to profit from the rapidly expanding AI industry?
The Biotech Stock That's Too Risky for Most Investors
Cory Renauer|Sep 28, 2025
It's unclear how long it's going to be before this company has a product to sell.
If You'd Invested $1,000 in Recursion Pharmaceuticals 4 Years Ago, Here's How Much You'd Have Today
Prosper Junior Bakiny|Aug 29, 2025
This AI company isn't yet living up to the hype.
1 Reason to Buy This Beaten-Down Artificial Intelligence (AI) Stock, and 2 Reasons to Sell
Prosper Junior Bakiny|Aug 25, 2025
There might be better artificial intelligence (AI) stocks out there to buy.
The Next Big Thing: 2 AI-Powered Healthcare Stocks Ready to Explode
James Brumley|Aug 23, 2025
The artificial intelligence revolution is leaving no opportunity unaddressed.
